Clinicopathologic correlations of liver kinase B1, E-Cadherin, and N-Cadherin expression in non-small cell lung cancer

Applied Immunohistochemistry and Molecular Morphology

Volumn 21, Issue 4, 2013, Pages 334-340

  Liu, Shuli ^a   Miao, Yuan ^a   Fan, Chuifeng ^a   Liu, Yang ^a   Yu, Juanhan ^a   Zhang, Yong ^a   Dai, Shundong ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

EMT; LKB1; lung adenocarcinoma; metastasis; prognosis

Indexed keywords

LIVER KINASE B1; NERVE CELL ADHESION MOLECULE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84880920112     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31826b128b     Document Type: Article

References (26)

1. TravisWD. Pathology of lung cancer. Clin ChestMed. 2011;32:669-692.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. Cancer J Clin. 2006;56:106-130.
3. Tomlinson IP, Houlston RS. Peutz-Jeghers syndrome. J Med Genet. 1997;34:1007-1011.
4. Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat. 1999;13:476-481.
5. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007;448:807-810.
6. Matsumoto S, Iwakawa R, Takahashi K, et al. Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene. 2007;26:5911-5918.
7. Gao B, Sun Y, Zhang J, et al. Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas. J Thorac Oncol. 2010;5:1130-1135.
8. Kim MJ, Jin G, Jheon HS, et al. LKB1 mutations are extremely rare in Korean non-small cell lung cancers. Cancer Genet Cytogenet. 2010;196:204-206.
9. Onozato R, Kosaka T, Achiwa H, et al. LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci. 2007;98:1747-1751.
10. Koivunen JP, Kim J, Lee J, et al. Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer. 2008;99:245-252.
11. Fenton H, Carlile B, Montgomery EA, et al. LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol. 2006;14:146-153.
12. Gao Y, Xiao Q, Ma H, et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci USA. 2010;107:18892-18897.
13. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 2010;29: 4741-4751.
14. Roy BC, Kohno T, Iwakawa R, et al. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer. 2010;70:136-145.
15. Travis WD, Brambilla E, Müller-Hermelink HK, et al. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC; 2004.
16. Travis WD, Brambilla E, Noguchi M, et al. International Association for the study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244-285.
17. Goldstraw P. Updated staging system for lung cancer. Surg Oncol Clin N Am. 2011;20:655-666.
18. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14:4085-4095.
19. Pardo OE, Latigo J, Jeffery RE, et al. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res. 2009;69:8645-8651.
20. Ghaffar H, Sahin F, Sanchez-Cepedes M, et al. LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res. 2003;9:2998-3003.
21. Miao Y, Liu N, Zhang Y, et al. p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients. Med Oncol. 2010;27: 880-886.
22. Prudkin L, Liu DD, Ozburn NC, et al. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol. 2009;22: 668-678.
23. Marcus AI, Zhou W. LKB1 regulated pathways in lung cancer invasion and metastasis. J Thorac Oncol. 2010;5:1883-1886.
24. Okuda K, Sasaki H, Hikosaka Y, et al. LKB1 gene alterations in surgically resectable adenocarcinoma of the lung. Surg Today. 2010; 41:107-110.
25. Shah U, Sharpless NE, Hayes DN. LKB1 and lung cancer: More than the usual suspects. Cancer Res. 2008;68:3562-3565.
26. Sanchez-Cespedes M, Parrella P, Esteller M, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 2002;62:3659-3662.